| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 549.2 | 557.9 | 430.8 |
| Other income | 0.5 | 2.0 | 3.5 |
| Total income | 549.8 | 559.9 | 434.3 |
| Profit before exceptional items & tax | -19.7 | -25.8 | -30.2 |
| Exceptional items | 0.0 | 0.0 | -26.7 |
| Profit before tax | -19.7 | -25.8 | -56.9 |
| Net profit | -15.2 | -19.3 | -41.6 |
| Operating margin | -3.6% | -4.6% | -13.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +27.50% |
|---|---|
| Operating profit, year on year | +40.10% |
| Operating profit, quarter on quarter | +27.30% |
BSE results filing, NSE: GODAVARIB. Figures extracted from the filing.
Godavari Biorefineries Ltd: key numbers
- Share price
- ₹227.90
- Market cap
- ₹1,166 Cr
- Revenue (annual)
- ₹1,988 Cr
- Net profit (annual)
- ₹3.53 Cr
- P/E (TTM)
- 5178.4×Sector 33.9×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Biorefineries Ltd
All →Godavari Biorefineries Results Update
Q2 FY27 revenue rose 26.6% YoY to Rs.549.8 Crore, with EBITDA turning positive. Net loss narrowed to Rs.15.2 Crore from Rs.41.6 Crore a year earlier.
Godavari Biorefineries Board Meeting Date
Godavari Biorefineries has given prior intimation of a board meeting on 4 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October until 48 hours after results.
Godavari Biorefineries Other Announcement
Godavari Biorefineries Ltd has submitted its quarterly shareholding pattern as per SEBI regulations. This is a routine regulatory compliance filing.
Godavari Biorefineries Patent
Godavari Biorefineries Ltd has been granted a US patent for a compound targeting cancer treatment. This patent covers a novel class of cancer-inhibiting compounds.
Godavari Biorefineries Other Announcement
Godavari Biorefineries Ltd submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended 30th September, 2026.
Godavari Biorefineries Patent
Godavari Biorefineries Limited has been granted a patent by the Mexican Patent Office for its invention concerning compounds for treating viral infections.